European Patent Office

T 0816/22 (C1-esterase inhibitor for AMR/TAKEDA) of 19.11.2024

European Case Law Identifier
ECLI:EP:BA:2024:T081622.20241119
Date of decision
19 November 2024
Case number
T 0816/22
Petition for review of
-
Application number
14809567.2
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
Abstract on Article 083 EPC
Application title
Methods of treating antibody-mediated rejection in organ transplant patients with C1-esterase inhibitor
Applicant name
Takeda Pharmaceutical Company Limited
Opponent name
CSL Innovation Pty Ltd
Board
3.3.04
Headnote
-
Relevant legal provisions
European Patent Convention Art 83
Keywords
Sufficiency of disclosure - reproducibility (no)
Catchword
-
Cited cases
-
Citing cases
-

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The patent is revoked.